Learn more

RIKEN

Overview
  • Total Patents
    2,706
  • GoodIP Patent Rank
    1,933
  • Filing trend
    ⇧ 8.0%
About

RIKEN has a total of 2,706 patent applications. It increased the IP activity by 8.0%. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are INST BIOPHYSICS CN ACAD SCI, SHANGHAI INST BIOL SCIENCES and UNIV BONN.

Patent filings per year

Chart showing RIKENs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yokoyama Shigeyuki 153
#2 Miyawaki Atsushi 118
#3 Hayashizaki Yoshihide 106
#4 Ohmori Hitoshi 69
#5 Sasai Yoshiki 68
#6 Taniguchi Masaru 66
#7 Yamagata Yutaka 65
#8 Takahashi Masayo 61
#9 Kase Kiwamu 59
#10 Hou Zhaomin 56

Latest patents

Publication Filing date Title
WO2021075519A1 Detection method and detection system for mastitis in domestic animal
WO2021075502A1 Cell sheet production device and cell sheet
WO2021070883A1 Human ntcp-binding antibody capable of inhibiting infection of hepatitis b virus (hbv) to human hepatocytes
WO2021066157A1 Novel fluorescent protein and utilization thereof
WO2021054441A1 Ferulic acid decarboxylase mutant derived from saccharomyces, and method for producing unsaturated hydrocarbon compound using same
WO2021060040A1 Assessment device, assessment method, program, and information recording medium
WO2021039884A1 Cell membrane-permeable vesicle
WO2021029368A1 Combined use of artificial adjuvant vector cells and an immunostimulant
WO2021020475A1 Laser device and method for manufacturing same
WO2021020356A1 Data interpretation device, method and program, data integration device, method and program, and digital city construction system
WO2021020262A1 Microscope, method for imaging sample by microscope, program, and control device
EP3766899A1 Antibody against human tgf-beta lap degradate and use thereof
WO2021010303A1 Therapeutic agent for disease caused by dominant mutant gene
WO2021015016A1 Conversion device, conversion method, program, and information recording medium
WO2021002476A1 Method and kit for detecting target nucleic acid fragment
WO2020262531A1 Primitive endoderm stem cell inducer
WO2020246229A1 Radiation dosimetry gel and radiation dosimeter provided with same as material for measuring radiation dose
WO2020241354A1 Radiation dosimetry gel and radiation dosimeter comprising same as material for measuring radiation dose
WO2020218480A1 Composite including neural retina, retinal pigment epithelial cells, and hydrogel, and method for producing same
WO2020213614A1 Device, method and program for environmental factor estimation, learned model and recording medium